Finance

Beta
Lists
237690:KOSDAQ
ST Pharm Co Ltd
â‚©122,200.00
+3.74%
(+4,400.00) 1D
Jun 11, 2:30:26 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 237690...
Open
â‚©114,100
High
â‚©124,400
Low
â‚©113,800
Mkt. cap
2.55T
Avg. vol.
149.76K
Volume
107.48K
Dividend
0.41%
Quarterly dividend
â‚©125
Ex-dividend date
Mar 30, 2026
P/E ratio
37.50
52-wk high
â‚©172,100
52-wk low
â‚©76,100
EPS
â‚©3,258
Shares outstanding
20.86M
No. of employees
655
Open
â‚©114,100
High
â‚©124,400
Low
â‚©113,800
Mkt. cap
2.55T
Avg. vol.
149.76K
Volume
107.48K
Dividend
0.41%
Quarterly dividend
â‚©125
Ex-dividend date
Mar 30, 2026
P/E ratio
37.50
52-wk high
â‚©172,100
52-wk low
â‚©76,100
EPS
â‚©3,258
Shares outstanding
20.86M
No. of employees
655
News stories
From sources across the web
About ST Pharm Co Ltd
CEOSung Moo-je
Employees655
Founded1983
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
68.25B
81.91B
129.10B
66.96B
Cost of goods sold
37.15B
45.91B
82.18B
36.89B
Cost of revenue
37.15B
45.91B
82.18B
36.89B
Research and development expenses
6.11B
6.68B
5.41B
6.51B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.66B
13.44B
12.75B
10.73B
Operating expense
18.18B
21.27B
20.66B
18.54B
Total operating expenses
55.33B
67.19B
102.84B
55.43B
Operating income
12.92B
14.72B
26.26B
11.53B
Other non operating income
-6.01B
6.25B
-614.92M
6.14B
EBT including unusual items
6.91B
20.98B
29.28B
17.67B
EBT excluding unusual items
6.91B
20.98B
22.67B
17.67B
Income tax expense
1.54B
3.52B
-1.75B
2.47B
Effective tax rate
22.33%
16.76%
-5.97%
13.96%
Other operating expenses
197.73M
182.89M
249.13M
189.97M
Net income
5.42B
17.57B
30.95B
15.06B
Net profit margin
7.95%
21.45%
23.97%
22.50%
Earnings per share
-
-
-
-
Interest and investment income
-
-
3.45B
-
Interest expense
-
-
-4.04B
-
Net interest expenses
-
-
-583.18M
-
Depreciation and amortization charges
678.78M
695.46M
512.37M
667.07M
EBITDA
19.52B
23.11B
34.57B
20.05B
Gain or loss from assets sale
12.52M
-5.70M
308.18M
279.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more